en
Scientific article
Open access
English

Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4⁺ T cell tolerance

Published inThe Journal of experimental medicine, vol. 211, no. 6, p. 1153-1166
Publication date2014
Abstract

Dendritic cells (DCs), and more recently lymph node stromal cells (LNSCs), have been described to tolerize self-reactive CD8(+) T cells in LNs. Although LNSCs express MHCII, it is unknown whether they can also impact CD4(+) T cell functions. We show that the promoter IV (pIV) of class II transactivator (CIITA), the master regulator of MHCII expression, controls endogenous MHCII expression by LNSCs. Unexpectedly, LNSCs also acquire peptide-MHCII complexes from DCs and induce CD4(+) T cell dysfunction by presenting transferred complexes to naive CD4(+) T cells and preventing their proliferation and survival. Our data reveals a novel, alternative mechanism where LN-resident stromal cells tolerize CD4(+) T cells through the presentation of self-antigens via transferred peptide-MHCII complexes of DC origin.

Citation (ISO format)
DUBROT ARMENDARIZ, Juan et al. Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4⁺ T cell tolerance. In: The Journal of experimental medicine, 2014, vol. 211, n° 6, p. 1153–1166. doi: 10.1084/jem.20132000
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0022-1007
671views
346downloads

Technical informations

Creation11.07.2014 16:46:00
First validation11.07.2014 16:46:00
Update time14.03.2023 21:30:49
Status update14.03.2023 21:30:49
Last indexation16.01.2024 11:32:10
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack